1. Home
  2. KTTA vs XYLO Comparison

KTTA vs XYLO Comparison

Compare KTTA & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • XYLO
  • Stock Information
  • Founded
  • KTTA 2020
  • XYLO 1999
  • Country
  • KTTA United States
  • XYLO Israel
  • Employees
  • KTTA N/A
  • XYLO N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • XYLO
  • Sector
  • KTTA Health Care
  • XYLO
  • Exchange
  • KTTA Nasdaq
  • XYLO NYSE
  • Market Cap
  • KTTA 5.5M
  • XYLO 6.4M
  • IPO Year
  • KTTA 2021
  • XYLO N/A
  • Fundamental
  • Price
  • KTTA $0.68
  • XYLO $4.85
  • Analyst Decision
  • KTTA
  • XYLO
  • Analyst Count
  • KTTA 0
  • XYLO 0
  • Target Price
  • KTTA N/A
  • XYLO N/A
  • AVG Volume (30 Days)
  • KTTA 142.8K
  • XYLO 2.2K
  • Earning Date
  • KTTA 08-12-2025
  • XYLO 07-22-2025
  • Dividend Yield
  • KTTA N/A
  • XYLO N/A
  • EPS Growth
  • KTTA N/A
  • XYLO N/A
  • EPS
  • KTTA N/A
  • XYLO N/A
  • Revenue
  • KTTA N/A
  • XYLO $29,858,000.00
  • Revenue This Year
  • KTTA N/A
  • XYLO $279.19
  • Revenue Next Year
  • KTTA N/A
  • XYLO N/A
  • P/E Ratio
  • KTTA N/A
  • XYLO N/A
  • Revenue Growth
  • KTTA N/A
  • XYLO N/A
  • 52 Week Low
  • KTTA $0.67
  • XYLO $2.70
  • 52 Week High
  • KTTA $7.50
  • XYLO $6.67
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 32.67
  • XYLO 41.74
  • Support Level
  • KTTA $0.67
  • XYLO $4.98
  • Resistance Level
  • KTTA $0.77
  • XYLO $5.13
  • Average True Range (ATR)
  • KTTA 0.04
  • XYLO 0.11
  • MACD
  • KTTA 0.01
  • XYLO -0.01
  • Stochastic Oscillator
  • KTTA 14.02
  • XYLO 0.00

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.

Share on Social Networks: